Jotamo José Come: Difference between revisions

Line 1:

'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.<ref>{{REFweb

'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for [[HIV]] prevention and related service delivery for adolescent boys and men in generalized [[HIV]] epidemics.<ref>{{REFweb

|url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/

|title=WHO to develop new guidelines on male circumcision

Line 18:

I have been working on the subject of [[VMMC|Voluntary Medical Male Circumcision]] (VMMC) in the Ministry of Health from 2009; and when the Male Circumcision Program was established in 2012, I was designated the National Coordinator. I’m also chairperson of the Hospital Breast Cancer Prevention and Treatment Committee.

I have been involved in studies related to HIV prevention, such as Infection Prevention and Male Circumcision, including on adverse events (type, severity and determinants of), service delivery models, costs analysis, and lay counsellor referrals to [[VMMC]].<ref>{{REFdocument

I have been involved in studies related to [[HIV]] prevention, such as Infection Prevention and Male Circumcision, including on adverse events (type, severity and determinants of), service delivery models, costs analysis, and lay counsellor referrals to [[VMMC]].<ref>{{REFdocument

|url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1

|title=Biographies of Guideline Development Group (GDG) members for WHO guidance

Line 31:

• [[Bias]]

@@ Line 1: / Line 1: @@
-'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.<ref>{{REFweb
+'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for [[HIV]] prevention and related service delivery for adolescent boys and men in generalized [[HIV]] epidemics.<ref>{{REFweb
   |url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/
   |title=WHO to develop new guidelines on male circumcision
@@ Line 18: / Line 18: @@
 I have been working on the subject of [[VMMC|Voluntary Medical Male Circumcision]] (VMMC) in the Ministry of Health from 2009; and when the Male Circumcision Program was established in 2012, I was designated the National Coordinator. I’m also chairperson of the Hospital Breast Cancer Prevention and Treatment Committee.
-I have been involved in studies related to HIV prevention, such as Infection Prevention and Male Circumcision, including on adverse events (type, severity and determinants of), service delivery models, costs analysis, and lay counsellor referrals to [[VMMC]].<ref>{{REFdocument
+I have been involved in studies related to [[HIV]] prevention, such as Infection Prevention and Male Circumcision, including on adverse events (type, severity and determinants of), service delivery models, costs analysis, and lay counsellor referrals to [[VMMC]].<ref>{{REFdocument
   |url=https://www.who.int/hiv/mediacentre/news/WHOVMMCGDG-Sep2018.pdf?ua=1
   |title=Biographies of Guideline Development Group (GDG) members for WHO guidance
@@ Line 31: / Line 31: @@
 {{SEEALSO}}
 • [[Bias]]